Abstract:Abstract Vascular ageing is a key risk factor for cardiovascular diseases and is characterised by a continuous decline in endothelial function. Despite progress in recent years, the molecular mechanisms for this deterioration remain incompletely understood. Long non-coding RNAs (lncRNAs) are a heterogeneous class of RNAs that have been shown to regulate gene expression and protein function, however, little is known about their role in the ageing-associated dysregulation of endothelial cell (EC) function. In this study, we aimed to identify and functionally characterise a novel ageing-regulated lncRNA in ECs. Using RNA sequencing data of cardiac ECs from 12 weeks young and 20 months old mice, we identified Mirial as an ageing-induced lncRNA (1.32-fold, p=0.ehab724.33565). MIRIAL is conserved between mice and humans and has no obvious coding potential. GapmeR-mediated silencing of MIRIAL in human umbilical vein ECs (HUVECs) decreased cell proliferation by 50%, migration by 24% (p=0.045) and basal angiogenic sprouting by 53% (p=0.0029), while increasing VEGF-A-stimulated sprouting by 50% (p=0.0139) and not affecting apoptosis or senescence. Subcellular fractionation of HUVECs revealed that MIRIAL was predominantly associated with the chromatin (80%). Pathway analysis of RNA sequencing data showed an overrepresentation of upregulated p53 target genes upon MIRIAL knockdown in HUVECs which was validated using qRT-PCR (1.8–5.2-fold increased). Using siRNA against p53 we showed that this effect is fully dependent on the presence of p53. Moreover, p53 and its phosphorylated form (Ser15) were both increased (1.8-fold, p=0.01 and 2.9-fold, p=0.02) after MIRIAL silencing. Intriguingly, RNA immunoprecipitation revealed that MIRIAL physically interacts with p53 (3.75-fold enriched, p=0.0067). To further study the interactome of MIRIAL, we performed RNA pulldown assays followed by mass spectrometry analysis of bound proteins, which identified the ageing-associated prohibitin (PHB) 1 and 2 to potentially interact with MIRIAL. Similar to MIRIAL knockdown, siRNA-mediated PHB 1 or 2 silencing caused proliferative defects. Further, PHBs are known to physically interact with p53 and control mitochondrial metabolism, a key factor in cellular ageing. Interestingly, silencing of MIRIAL in HUVECs increased mitochondrial mass (1.8-fold, p=0.0008) and spare respiratory capacity (1.95-fold) with the latter being decreased in isolated aged murine ECs. Taken together, MIRIAL is an ageing-induced lncRNA in ECs acting as a key regulator of metabolic and cellular function. MIRIAL promotes cell proliferation, migration and basal angiogenic sprouting while decreasing mitochondrial function and VEGF-A-stimulated sprouting. We hypothesise that MIRIAL influences p53 signalling and mitochondrial respiration through PHB 1 and 2. The present study suggests that modulation of MIRIAL expression may be a promising strategy to prevent or even reverse ageing-induced functional decline of ECs. Funding Acknowledgement Type of funding sources: Public grant(s) – EU funding. Main funding source(s): European Research Council (ERC) Starting Grant: Non-coding RNA in Vascular Ageing (NOVA)

The mitochondrial lncRNA ASncmtRNA-2 is induced in aging and replicative senescence in Endothelial Cells

The role of mitofusin 2 in regulating endothelial cell senescence: Implications for vascular aging

Mitochondrial-related microRNAs and their roles in cellular senescence

Mitochondrial (Dys) Function in Inflammaging: Do MitomiRs Influence the Energetic, Oxidative, and Inflammatory Status of Senescent Cells?

Mitochondrial RNA cytosolic leakage drives the SASP

The lncRNA OIP5-AS1/miR-4500 axis targeting ARG2 modulates oxidative stress-induced premature senescence in endothelial cells: implications for vascular aging

Unravelling the impact of aging on the human endothelial lncRNA transcriptome

Mitochondria are required for pro‐ageing features of the senescent phenotype

MicroRNA expression with “aging” in human aortic endothelial cells

Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells

ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties

MicroRNA-34a Induces Vascular Smooth Muscle Cells Senescence by SIRT1 Downregulation and Promotes the Expression of Age-Associated Pro-inflammatory Secretory Factors.

The novel ageing-induced long non-coding RNA MIRIAL controls endothelial cell and mitochondrial function

Noncoding RNAs in Vascular Aging

Endothelial Cell Aging: How miRNAs Contribute?

Role of MicroRNA-145 in DNA Damage Signalling and Senescence in Vascular Smooth Muscle Cells of Type 2 Diabetic Patients

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

Spinster homolog 2 (SPNS2) deficiency drives endothelial cell senescence and vascular aging via promoting pyruvate metabolism mediated mitochondrial dysfunction

Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells

Abstract 285: Oxidized Low Density Lipoprotein and Angiotensin II Causes Vascular Senescence Via AT1R Signal-mediate Mitochondrial Fission

Replicative senescence and high glucose induce the accrual of self-derived cytosolic nucleic acids in human endothelial cells